JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED – Trademark Portfolio
Entity Type: 99
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include CHY, FMI, JAYHOO, and MCUUINA. The owner is based in CENTRAL.
UNIT 2508A,25/F BANK OF AMERICA TOWER 12
HARCOURT ROAD
CENTRAL 999077 , HK
Showing of trademarks Trademarks
Trademark Classifications
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED have?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED file in?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's most well-known trademarks?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's registered trademark portfolio includes well-known marks such as CHY, FMI, JAYHOO, and MCUUINA. These are among 4 currently registered trademarks in the portfolio.
What is JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED's trademark registration success rate?
JAYHOO INTERNATIONAL PHARMACEUTICAL CO., LIMITED has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.